FDA 510(k)

Advantis 平台

K号: K222975 · 2023-03-01

申请人Advantis Medical Imaging Single Member P.C.

决定日期2023-03-01

产品代码LLZ

咨询委员会RA

决定实质等同

器械摘要

Advantis Platform is the device name listed in this FDA 510(k) record. The listed applicant is Advantis Medical Imaging Single Member P.C.. It received FDA 510(k) clearance on 2023-03-01 under 510(k) number K222975. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Advantis Platform?

Advantis Platform is a medical device that received FDA 510(k) clearance on 2023-03-01. The listed applicant is Advantis Medical Imaging Single Member P.C.. The 510(k) number is K222975.

When did Advantis Platform receive FDA 510(k) clearance?

Advantis Platform received FDA 510(k) clearance on 2023-03-01, under 510(k) number K222975.

Who is the listed applicant for Advantis Platform?

The FDA 510(k) record lists Advantis Medical Imaging Single Member P.C. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Advantis Platform?

The FDA product code for Advantis Platform is LLZ.

列明Advantis Medical Imaging Single Member P.C.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K202808Brainance MD

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。